FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
04/19/2025
Back to search
Official data from USPTO
SPOT-MAS MULTI-CANCER EARLY DETECTION
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
25
Latest update
04/03/2026
Trademark type
Combined
Nice classes
10, 42, 44
Filing date
04/03/2023
Registration date
10/29/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/29/2024
Last transaction
04/03/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
3
Owner type
99
Owner location
VN
Examiner
CLARK, ROBERT C
Law office
L10
Current location
FILE REPOSITORY (FRANCONIA)
Mark description
The mark consists of the stylized curved strip device appearing in blue, purple and pink, the phrase "SPOT-MAS" appearing in pink over "MULTI-CANCER EARLY DETECTION" appearing in pink.
Holders and representatives
Holders
GENE SOLUTIONS JOINT STOCK COMPANY
Representatives
James Walters patenttm.us
Technical classification
Nice Classes
Class 10Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 10
Medical apparatus and instruments for use in gene sequencing procedures; Medical diagnostic apparatus for testing cancer cellsincorporating recorded software for cancer treatment and monitoring; medical apparatus for use in analyzing genes for diagnostic and treatment purposes; medical diagnostic apparatus for genetic diseases
Class 42
Scientific research services on genes; scientific research in the field of genetics; scientific research and analysis in the field of gene sequencing; scientific laboratory services for scientific research purposes
Class 44
Medical analysis services relating to the treatment of persons; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical screening services; telemedicine services
Publications
History of USPTO decisions and trademark events.
25 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
04/01/2025
FIMP
FINAL DISPOSITION PROCESSED
04/01/2025
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
01/29/2025
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
01/10/2025
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
12/25/2024
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
12/25/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
10/29/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
10/29/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/13/2024
PUBO
PUBLISHED FOR OPPOSITION
08/13/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07/24/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/02/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/02/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/01/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/01/2024
RFNT
REFUSAL PROCESSED BY IB
02/06/2024
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
01/17/2024
RFRR
REFUSAL PROCESSED BY MPU
01/16/2024
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
01/03/2024
CNRT
NON-FINAL ACTION WRITTEN
01/02/2024
DOCK
ASSIGNED TO EXAMINER
12/29/2023
MAFR
APPLICATION FILING RECEIPT MAILED
08/01/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/28/2023
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
07/27/2023
Continuous trademark protection
Get notified about every new filing that threatens SPOT-MAS MULTI-CANCER EARLY DETECTION or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.